CD8A and neoplasm: Furthermore, high levels of OPN are significantly associated with poor clinical outcome in patients bearing highly metastatic tumors [11]: stromal OPN directly suppresses CD8+ T cell proliferation and activation [12], and in parallel, sustains MDSCs colonization, thus supporting tumor progression [13].